Government Health The Sciences DCGI Approves Virafin for Moderate COVID. Where’s the Evidence It Works? Ronak Borana 24/04/2021 0 Virafin's phase 2 trial has several methodological and reporting...Read More
Government Health The Sciences Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque? Anupam Kumar Singh and Dinesh Thakur 31/07/2020 0 It's not clear how the Drug Controller General of...Read More
